Bleeding, Clotting & Hypercoagulable Disorders

Connect the balance of normal hemostasis with bleeding patterns, coagulation-screen interpretation, major bleeding disorders and the mechanisms that shift the same system toward thrombosis.

Structure follows the supplied AIM Concept Integration specification. :contentReference[oaicite:0]{index=0}

1. THE TOPIC IN ONE CONNECTED FLOW

Hemostasis normally balances clot formation and clot control. A defect in platelets, von Willebrand factor or coagulation factors produces bleeding, while excessive coagulation, endothelial injury or blood stasis promotes thrombosis. The clinical pattern and coagulation screen help identify which side of this balance is disturbed.

Vessel Injury
Normal hemostatic response begins

→

Platelet Adhesion
vWF supports platelet attachment

→

Coagulation Cascade
Thrombin generates fibrin

→

Stable Clot
Platelet plug reinforced by fibrin

If hemostasis fails → BLEEDING

Platelet / vWF defect
→
petechiae, purpura, epistaxis, mucosal bleeding
→
platelet count / BT / vWF assessment

Coagulation-factor defect
→
hemarthrosis, muscle hematoma, delayed bleeding
→
PT / APTT interpretation

If clotting is excessive → THROMBOSIS

Hypercoagulability + stasis + endothelial injury
→
pathological thrombus
→
DVT / pulmonary embolic risk

Identify inherited or acquired risk
→
anticoagulation or prophylaxis when appropriate
→
reduced recurrence

2. KEY CLINICAL CONNECTIONS

Bleeding Pattern → Defect → Test

Petechiae / mucosal bleeding
→
primary hemostasis defect
→
platelet count and vWF-related evaluation

Hemarthrosis / deep bleeding
→
coagulation-factor defect
→
PT/APTT pattern guides localization

Laboratory Pattern → Diagnostic Meaning

Low platelets + normal PT/APTT
→
isolated platelet-number disorder such as ITP

Prolonged PT/APTT + low fibrinogen + raised FDPs
→
consumptive coagulopathy such as DIC

Mechanism → Treatment Principle

Factor VIII deficiency
→
defective fibrin stabilization
→
Factor VIII replacement

vWF deficiency
→
impaired platelet adhesion
→
desmopressin or vWF-containing concentrate when appropriate

3. AIM HIGH-YIELD INTEGRATION REVIEW

⭐ Platelet / vWF dysfunction
→
superficial and mucosal bleeding
→
think primary hemostasis.

⭐ Coagulation-factor deficiency
→
weak fibrin reinforcement
→
delayed deep bleeding and hemarthrosis.

Hemophilia A
→
Factor VIII deficiency
→
isolated prolonged APTT with normal platelet count and PT
→
Factor VIII replacement.

von Willebrand disease
→
defective platelet adhesion plus reduced Factor VIII stabilization
→
mucosal bleeding with normal platelet count.

ITP
→
immune platelet destruction
→
thrombocytopenia with petechiae / purpura
→
PT and APTT remain normal.

⭐ DIC
→
widespread coagulation activation
→
consumption of platelets and factors
→
prolonged PT/APTT, low fibrinogen and raised FDPs.

⭐ Hypercoagulability
→
inherited or acquired prothrombotic tendency
→
combines with stasis / endothelial injury
→
thrombosis risk.

AIM Exam Trap:

Low platelets + normal PT/APTT
→
think platelet-number disorder;
normal platelets + isolated prolonged APTT
→
think intrinsic-pathway factor disorder;
low platelets + prolonged PT/APTT + low fibrinogen + raised FDPs
→
think DIC.